Intro
There is a number on most lab panels that almost no one is reading correctly.
It sits quietly next to LDL and HDL. It rarely gets discussed. When it does, it is usually dismissed as a downstream consequence of high triglycerides, or treated as a minor contributor to cardiovascular risk.
That number is VLDL.
And it is not what we have been told it is.
---
Start With Something Familiar
Think about HbA1c for a moment.
A1C is not a disease. It is not a risk factor in the way LDL is treated as a risk factor. It is something more useful than either of those things.
It is a window.
A1C tells us how a system — glucose handling — has been behaving over time. It integrates weeks of biology into a single number. When A1C is high, no clinician asks whether the number itself is the problem. They ask what the body is doing that produced it.
That is the right question. And it is the question we have forgotten to ask about the liver.
---
The Liver Has Been Speaking. We Have Not Been Listening.
The liver is the central processing organ for energy in the body. It takes in substrate, decides what to store, what to burn, and what to send out into circulation for the rest of the body to use.
When the liver sends energy out, it sends it out as VLDL.
VLDL is the liver's export vehicle. It is how the liver packages triglycerides and ships them to the tissues that need fuel. The amount of VLDL the liver produces, and the conditions under which it produces it, are a direct readout of what the liver is being asked to do.
Read that sentence again.
The amount of VLDL the liver produces is a direct readout of what the liver is being asked to do.
That is not a risk factor. That is a function marker.
---
The Same Logic, A Different Organ
A1C tells us how glucose handling has been behaving over time.
VLDL tells us how hepatic energy handling has been behaving over time.
Same logic. Different organ.
When VLDL is elevated, the liver is telling us something specific about its substrate load, its insulin signaling environment, and its workload — long before any structural disease shows up on imaging or in liver enzymes. The signal is early. The signal is honest. The signal is already on the lab panel.
We just have to read it the way we read A1C.
---
Why This Matters
Once VLDL is read as a function marker rather than a risk factor, several things change.
The liver moves to the center of the conversation, where it belongs. The downstream numbers — LDL, HDL, the atherogenic pattern — start to make sense as consequences of one upstream signal rather than independent findings to be chased one at a time. And the clinician stops asking "how do I lower this number" and starts asking the better question, the A1C question.
What is the liver doing that produced this?
That is the question this series is going to answer.
---
Where This Series Is Going
If you have read the triglyceride series on this site, this idea will feel familiar. That series was the foundation. This one builds on it.
In the posts that follow, we will look at what VLDL actually is and why the liver makes it, why it has been so widely misunderstood, and what it tells us about insulin sensitivity, kidney function, brain health, the heart, and the pancreas — the organ that closes the loop.
By the end, the same number that has been sitting quietly on the lab panel for years should look very different.
It should look like what it is.
The A1C of the liver.